Print

Print


Joe,
 
I agree with your analysis.  There is a continuum of myocardial cell insult from ischaemia, through minimal necrosis up to "significant" necrosis.  Troponin T will increase at a particular point along that continuum (when ischaemia develops into necrosis).  With our methods we can determine biochemically (and analytically) when troponin increases from a given reference point.  This will be interpreted as myocardial death. Higher levels of troponin (at 12 hours for example) would indicate higher amounts of myocardial death. However I cannot see how we can determine biochemically, with troponin alone, when the increasing myocardial death, (and increasing troponin) becomes consistent with what is called an AMI.  
 
We can show that an event is acute, if we measure at troponin at at least two time points. 
 
Martin Myers
-----Original Message-----
From: Clinical biochemistry discussion list [mailto:[log in to unmask]]On Behalf Of Indovina, Joe [OCDUS]
Sent: 03 December 2008 13:19
To: [log in to unmask]
Subject: Re: Troponins reporting


Ian you recall correctly. Presence of circulating troponin above the 99th percentile by itself does not indicate AMI but does indicate myocardial cell insult.  After having worked with this assay for several years, it is my feeling that presence of troponin is part of a continuum of myocardial cell insult from minimal damage through to AMI. There is building data that presence above the 99th percentile is a prognostic indicator of long term outcome. 
Chris I agree with your approach and thinking in that troponin must be looked at in context. I wonder too if we have done a good enough job educating physicians. Initially troponin was discussed as a marker for AMI. As I have learned more, listened to talks, and had the opportunity to discuss and work with this assay with investigators, I now believe it is an indicator of subtle myocardial cell death yet the patient may not be at a AMI diagnosis. Other causes may be at play
 
What do others think?
In regards to the table, most of the vendors AMI cutoff I was able to confirm was developed on evidence of AMI. The table and the table that Dr. Jim Miller sent around was meant to show the importance (to me) of clearly identifying the expected values and method of the troponin. Numerical commutability method to method is difficult. 
 
 
 
 
-----Original Message-----
From: Clinical biochemistry discussion list [mailto:[log in to unmask]]On Behalf Of IAN WATSON
Sent: Wednesday, December 03, 2008 7:37 AM
To: [log in to unmask]
Subject: Re: Troponins reporting
 
If I recall correctly Fred Apple talked about this at AACC this year. If above the 99th centile that is ACS not necessarily AMI.  On-admission and 6h sampling with 12 hour if on admission not raised. Values > 0.01ng/ml for Trop T meant cardiac damage and if it wasn't rising it was chronic. According to me the LLQ for this assay is 0.03ng/ml, but he may have a super-sensitive assay. Makes sense if we could do it?
 
Ian
 
Dr Ian D Watson
Consultant Biochemist & Toxicologist
Dept Clinical Biochemistry
University Hospital Aintree
Lower Lane
Liverpool
L9 7AL
Tel +44 151 529 3575
Fax +44 151 529 3310
 
Fundamentals of Analytical Toxicology recently published:
http://eu.wiley.com/WileyCDA/WileyTitle/productCd-0470319356.html
 
 
 
From: Clinical biochemistry discussion list [mailto:[log in to unmask]] On Behalf Of SERGEANT Chris (RF4) BHR Hospitals
Sent: 03 December 2008 10:48
To: [log in to unmask]
Subject: Re: Troponins reporting
 
We use a testing strategy that includes the possibility of repeat analysis to observe changes in troponin concentration when diagnosis is uncertain We have advised clinicians of the manufacturers quoted 99th centile cutoff as this is the concentration, according to the guidelines, consistent with AMI. As stated below, other evidence of myocardial ischaemia is important for the diagnosis, as well as a "rise and or fall".  The clinical specifity and sensitivity of the lab result is not only affected by setting the "cutoff" at the 99th centile but also the timing of the sample(s) in relation to symptoms and the reproducibility of the assay. We try to ensure clinicans do not simply see a single TNI result (often taken at varying times post symptoms) as a simple "yes" or "no" number, although this is often what they want.
 
Chris
 
-----Original Message-----
From: Clinical biochemistry discussion list [mailto:[log in to unmask]]On Behalf Of Myers Martin (LTHTR)
Sent: 03 December 2008 10:08
To: [log in to unmask]
Subject: Re: Troponins reporting
I am a little uneasy about the "AMI Cut offs" that would indicate AMI.   Are these evidence based?  What does an arbitary cut off, e.g. 0.1 for troponin T (at a fixed time point of 12 hr), actually mean and how would one interpret the following:
admission TnT = <0.01
12 hour troponin T = 0.09
 
The Expert Consensus Document, Universal Definition of Myocardial Infarction, Circulation 2007;116;2634-2653;  defines a acute myocardial infarction as (amongst others) : a rise and/or fall in [troponin] with at least one level above the 99th percentile of the URL together with evidence of myocardial ischaemia (at least one of the following: symptoms, ECG changes, pathological Q wave, imaging evidence).  There is not mention of another arbitary cut-off which would indicate AMI.  
 
martin
 
 
-----Original Message-----
From: Clinical biochemistry discussion list [mailto:[log in to unmask]]On Behalf Of Indovina, Joe [OCDUS]
Sent: 02 December 2008 18:39
To: [log in to unmask]
Subject: Re: Troponins reporting
Good discussion
 
To help I went through my files and put together a table of different vendors troponin assay cut offs and 99% URL
 
I used the package insert sheets that I have and thus urge caution as some may not be 100% current
 
What it does show is, in my opinion, the importance of identifying on the lab report as Mohammad does

 
Abbott AxSYM TnI ADV
Abbott AxSYM TnI ADV
Beckman AccuTnI
Bayer Centaur Ultra TnI
Dade RXL
DPD STAT TnI
Roche TnT
Vitros Trop I ES
 

 
 
 
 
 
 
 
 
 
 

AMI Cut-off
0.4
0.3
0.5
0.8
1.5
??
0.1
0.120
 

 
 
 
 
 
 
 
 
 
 

URL 99th Percentile
<= 0.04
0.012
<= 0.04
0.04
<= 0.05
0.2
0.01
0.034
 

 
 
 
 
 
 
 
 
 
 

units
ng/mL
 
 
 
 
 
 
 
 

 
 
 
 
 
 
 
 
 
 
 
 
 
-----Original Message-----
From: Clinical biochemistry discussion list [mailto:[log in to unmask]]On Behalf Of Mohammad Al-Jubouri
Sent: Tuesday, December 02, 2008 9:06 AM
To: [log in to unmask]
Subject: Troponins reporting
 
There are various cut offs used for TnT and TnI reporting. The following aucomms are added to our TnI reports (Advia Centaur TnI ultra assay) using the manufacturer's recommendations:
 
< 0.05 ug/L           No obvious myocardial damage.
 
0.05 - 0.78 ug/L   Myocardial damage consistent with acute coronary syndrome and/or NSTEMI
 
> 0.78 ug/L          Myocardial damage consistent with acute MI (WHO criteria)
 
Always interpret TnI results within the clinical context and ECG findings.
Above comments apply to samples taken 12h post-event.
 
All these comments are designed to enlighten the user about how to interpret the TnI test result, however it seems that a lot of patients with positive TnI results are labelled as acute MI despite the absence of other criteria to diagnose myocardial ischaemia. 
 
How do other people report their Troponin results?
Is there a better way of reporting lab tests using test's sensitivity/specificity and positive/negative predictive values, rather than just reporting a numerical result with a reference range of dubious origin?
 
Many thanks
 
Mohammad
 
 

  _____  

From: Mohammad Al-Jubouri <[log in to unmask]>
To: [log in to unmask]
Sent: Monday, 1 December, 2008 15:54:04
Subject: Re: Troponin I - quoted cut-off value 0.10 ug/L
Richard,
 
We actually use 0.05 ug/L as the cut off for detecting myocardial damage (not classical MI cut off) on the Advia Centaur TnI ultra assay. As myocardial damage can be of varying aetiology ischaemic & non-ischaemic, we leave it to the clinicians to decide if the myocardial damage is due to acute coronary ischaemia or due to some other causes. 
 
David's original statement is probably related to a recent NEQAS interpretative comment.
 
Best wishes
 
Mohammad
 
 
 

  _____  

From: Mainwaring-Burton Richard (RGZ) <[log in to unmask]>
To: [log in to unmask]
Sent: Monday, 1 December, 2008 15:34:36
Subject: Re: Troponin I - quoted cut-off value 0.10 ug/L
THAT IS WRONG !!!
0.1   is the M.I. cutoff for TnT and NOT TnI !
 
I suspect that the 0.1 value may be the lowest claimed detectable for TnI
 
Read ALL the small print, not just the box.
 
I never trust what it says on the box : I keep seeing "Open Other End " - and it never is !
with best wishes 
Richard 
Richard Mainwaring-Burton 
Consultant Biochemist 
Queen Mary's Hospital 
Sidcup, Kent 
020-8308-3084 
-----Original Message-----
From: Mohammad Al-Jubouri [mailto:[log in to unmask]] 
Sent: 01 December 2008 15:05
To: [log in to unmask]
Subject: Re: Troponin I - quoted cut-off value 0.10 ug/L
 
I interpret it as any TnI value of 0.1 ug/L and above indicates myocardial damage, and any value < 0.1 ug/L does not indicate myocardial damage.
 
regards
 
Mohammad 
 
Dr. M A Al-Jubouri, MB ChB, MSc, FRCP Edin, FRCPath
Consultant Chemical Pathologist 
 
 

  _____  

From: David Burgess <[log in to unmask]>
To: [log in to unmask]
Sent: Monday, 1 December, 2008 14:58:32
Subject: Troponin I - quoted cut-off value 0.10 ug/L

Please - how do you interpret the phrase, "Troponin I was analysed on an 
Advia Centaur: quoted cut-off value 0.10 ug/L"
Regards, David.

------ACB discussion List Information--------
This is an open discussion list for the academic and clinical
community working in clinical biochemistry.
Please note, archived messages are public and can be viewed
via the internet. Views expressed are those of the individual and
they are responsible for all message content.
ACB Web Site
http://www.acb.org.uk <http://www.acb.org.uk/> 
List Archives
http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html
List Instructions (How to leave etc.)
http://www.jiscmail.ac.uk/
 
------ACB discussion List Information-------- This is an open discussion list for the academic and clinical community working in clinical biochemistry. Please note, archived messages are public and can be viewed via the internet. Views expressed are those of the individual and they are responsible for all message content. ACB Web Site http://www.acb.org.uk List Archives http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html List Instructions (How to leave etc.) http://www.jiscmail.ac.uk/ ------ACB discussion List Information-------- This is an open discussion list for the academic and clinical community working in clinical biochemistry. Please note, archived messages are public and can be viewed via the internet. Views expressed are those of the individual and they are responsible for all message content. ACB Web Site http://www.acb.org.uk List Archives http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html List Instructions (How to leave etc.) http://www.jiscmail.ac.uk/

------ACB discussion List Information-------- This is an open discussion list for the academic and clinical community working in clinical biochemistry. Please note, archived messages are public and can be viewed via the internet. Views expressed are those of the individual and they are responsible for all message content. ACB Web Site http://www.acb.org.uk List Archives http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html List Instructions (How to leave etc.) http://www.jiscmail.ac.uk/
 
------ACB discussion List Information-------- This is an open discussion list for the academic and clinical community working in clinical biochemistry. Please note, archived messages are public and can be viewed via the internet. Views expressed are those of the individual and they are responsible for all message content. ACB Web Site http://www.acb.org.uk List Archives http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html List Instructions (How to leave etc.) http://www.jiscmail.ac.uk/

*******************************************************************************

This email is confidential  and intended solely  for the use of the  individual

to  whom  it  is  addressed.  Any views or opinions  presented are solely those

of the author and do not necessarily represent  those of  the  Organisation. If

you are not the  intended   recipient,  be  advised  that   you  have  received

this  email in  error  and  that  any  use, dissemination, forwarding, printing

or copying  of this  email is  strictly  prohibited. If  you have received this

email in  error  please  notify  the  sender.  This  e-mail  has  been  checked

for  viruses  using  anti-virus  software  





*******************************************************************************

This email is confidential  and intended solely  for the use of the  individual

to  whom  it  is  addressed.  Any views or opinions  presented are solely those

of the author and do not necessarily represent  those of  the  Organisation. If

you are not the  intended   recipient,  be  advised  that   you  have  received

this  email in  error  and  that  any  use, dissemination, forwarding, printing

or copying  of this  email is  strictly  prohibited. If  you have received this

email in  error  please  notify  the  sender.  This  e-mail  has  been  checked

for  viruses  using  anti-virus  software  




------ACB discussion List Information-------- This is an open discussion list for the academic and clinical community working in clinical biochemistry. Please note, archived messages are public and can be viewed via the internet. Views expressed are those of the individual and they are responsible for all message content. ACB Web Site http://www.acb.org.uk List Archives http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html List Instructions (How to leave etc.) http://www.jiscmail.ac.uk/ ------ACB discussion List Information-------- This is an open discussion list for the academic and clinical community working in clinical biochemistry. Please note, archived messages are public and can be viewed via the internet. Views expressed are those of the individual and they are responsible for all message content. ACB Web Site http://www.acb.org.uk List Archives http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html List Instructions (How to leave etc.) http://www.jiscmail.ac.uk/


This message and any files transmitted with it are confidential and
intended solely for the individual(s) addressed. If you have
received this e-mail in error then please note that disclosing,
copying, distributing or retaining this message or any part of it
is strictly prohibited.  Please notify the sender immediately and
delete it from your system.  Any views or opinions presented are
solely those of the author and do not necessarily represent those
of Lancashire Teaching Hospitals NHS Foundation Trust. 

The Trust accepts no liability for any damage caused by any virus
transmitted with this e-mail, so although it has been virus checked
before transmission, the recipient should also check for the
presence of viruses.



The information contained in this email may be subject to public
disclosure under the NHS Code of Openness or the Freedom of
Information Act 2000.  Unless the information is legally exempt
from disclosure, the confidentiality of this email and any
subsequent reply cannot be guaranteed.



http://www.lancsteachinghospitals.nhs.uk


 


------ACB discussion List Information--------
This is an open discussion list for the academic and clinical
community working in clinical biochemistry.
Please note, archived messages are public and can be viewed
via the internet. Views expressed are those of the individual and
they are responsible for all message content.
ACB Web Site
http://www.acb.org.uk
List Archives
http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html
List Instructions (How to leave etc.)
http://www.jiscmail.ac.uk/